Investor Presentaiton

Industry-Leading Returns and Financial Strength Vision S&P 600 (1) Specialty Chemicals (2) Ingevity Revenue Growth 2.5 - 3x GDP ~GDP 2.5 - 3x GDP Adjusted EBITDA (3) ~14.0% ~20.0% 25 30+% Margins ROIC Capital Structure ~11.0% ~16.0% + 20% 2.5x Net Leverage 3.0x Net Leverage - 2.0 2.5x Net Leverage 18 Source: Company information and FactSet (1) S&P 600 reflects 5 year average (2012 - 2016). Excludes financial institutions, mortgage and REIT companies (2) Specialty Chemicals reflects 5 year average (2012 - 2016) of companies within the Dow Jones U.S. Specialty Chemicals Index (3) Please see appendices included at the end of this presentation for Ingevity's use of non-GAAP financial measures, definitions of those financial measures as well as the reconciliation to the nearest GAAP financial measure. Ingevity

View entire presentation